TP53 and adenocarcinoma: In the HPVa group, 69% and 6% of patients with UEA, 80% and 7% of patients with mucinous not otherwise specified (NOS), and 100% and 0% of patients with adenocarcinoma NOS demonstrated positive staining for p16 and aberrant staining for p53, respectively.